Novo Nordisk (Ozempic)

9294.34 - 9326.261 David Rosenthal

Yeah, so obviously other big pharma companies have not just been completely ignoring this incredible development slash cash gusher that has emerged in Novo Nordisk land. Eli Lilly now has a GLP-1 diabetes-approved treatment on the market under the diabetes brand name Monjaro that seems to be as if not more effective as semaglutide in terms of weight loss when used for obesity.